I think the point you're also making is about innovation and competitiveness. One of the first things I worked on here was with James Rajotte on this committee. It used to be allowable for companies to deduct environmental fines and penalties, and other malfeasance fines and penalties, as business-related expenses. We got that stopped.
It was unbelievable. It was like you were driving to work and got a ticket and you'd just claim, “Well, I had to get to work quicker, so I can write it off.” Drug companies were doing that—all kinds of different organizations. Some fines were up to $11 million.
At any rate, the point is that it took away from the good actors having to compete against the bad actors, who used that as a business-related expense for advantages.
My last question for you in regard to this is that this will have a chance to go through the Senate later. If, later on, there were an issue over trade agreements, that's going to get another analysis in the Senate that would be more robust. Perhaps it might give the government some backbone to deal with some of these other contentious issues that I listed with the United States.